Copyright

(c) 2010-2024 Jon L Gelman, All Rights Reserved.
Showing posts with label National Cancer Institute. Show all posts
Showing posts with label National Cancer Institute. Show all posts

Thursday, December 5, 2013

ADAO Resource: How To Find a Doctor or Treatment Facility Specializing in Mesothelioma and Asbestos-Related Diseases

Seeking information about medical treatment concerning mesothelioma? The information made available by the ADAO makes the process less difficult, Especially during challenging moments.Today's post was shared by Linda Reinstein and comes from www.asbestosdiseaseawareness.org

Posted on December 4, 2013*Note: From the very founding of our organization, ADAO has abstained from providing any medical or legal referrals. ADAO remains an independent organization that is not influenced by outside sources, such as drug companies, law firms, or companies that manufacture or use asbestos.

Many of us can think back to the heartbreaking time when we first heard the news that a loved one had an asbestos-caused disease. “Mesothelioma – can’t pronounce it, can’t cure it,” was my devastated, personal reaction. It took me many weeks to even begin to understand the diagnosis my husband had received and find the very limited treatment options available to him.

My learning curve was steep and Alan was diagnosed before the advancement of the smart phone.

Navigating the health care system maze is complex – but it shouldn’t be. The Asbestos Disease Awareness Organization (ADAO) is committed to replacing those feelings of fear, loneliness and confusion with the knowledge that there are others who share your experience and want to support you.

We want you to have easy access to information about medical resources for asbestos-caused diseases. The National Cancer Institute has an excellent page, in English and Spanish, to answer your questions on “How To Find a Doctor or Treatment Facility...
[Click here to see the rest of this post]

Thursday, October 31, 2013

DePaolo's Work Comp World: Trucks, WBV and Cancer

The National Cancer Institute (NC!) reports that over 230,000 males in the US will diagnosed with prostate cancer in 2013 and that 29,790 deaths will result. David DePaolo, published of WorkCompCentral®, writes today of the potential new wave of workers' compensation claims arising from the association of whole-body vibration syndrome (WBV) experienced by truck drivers and its relationship to prostate cancer. He links source material to support the argument. This post is shared from http://daviddepaolo.blogspot.com .

You just never know what the next big risk category is going to be in workers' compensation.
I had been persuaded by an argument offered by Charlie Kingdollar, Vice President emerging issues unit for General Re Corp., that nanomaterials would be the next asbestos.

OSHA has been particularly concerned with silica in the past couple of years.

Thursday, January 13, 2011

New Drug May Be Effective Against Mesothelioma

Recent research by Japanese scientists have been reported effective against malignant pleural mesothelioma [MPM], a rare cancer associated with asbestos exposure. The drug, named S-1, has been developed as a novel oral antineoplastic agent "based on the modulation of 5-fluorouracil (5-FU) bioactivity."

The scientists used three human MPM cell lines, Y-MESO-14, NCI-H290 and MSTO-211H. In vitro proliferation of human MPM cells was determined by MTT assay. Human MPM cells were orthotopically implanted into thoracic cavity of SCID mice. Tumor-bearing mice were treated with S-1 or vehicle.

"The combination of 5-FU and 5-chloro-2,4-dihydroxypyridine (CDHP) was more effective than 5-FU alone in inhibiting MPM cell proliferation in vitro. This combination was most effective in Y-MESO-14 cells, which co-expressed high protein level of dihydropyrimidine dehydrogenase (DPD) and thymidine phosphorylase (TP). In vivo data showed that treatment with S-1 significantly reduced thoracic tumors and pleural effusion produced by Y-MESO-14 cells. Moreover, treatment with S-1 prolonged the survival of Y-MESO-14 cell-bearing SCID mice."

They concluded, "We demonstrated that S-1 was effective for inhibiting the proliferation of MPM cells, particularly with both DPD and TP expressions, suggesting that S-1 might be therapeutically effective for control of MPM."

CANCER CHEMOTHERAPY AND PHARMACOLOGY DOI: 10.1007/s00280-010-1503-x

Friday, December 3, 2010

National Mesothelioma Awareness Day Resolution Approved by Congress

The US House of Representative has passed a resolution designating September 26 as National Mesothelioma Awareness Day. The action came as the US House of Representatives unanimously, by roll call vote, approved the passage of a resolution (H. Res. 771). Representative Betty McCollum introduced the resolution that was supported by 58 co-sponsors.

The action by the House of Representatives follows prior approval of an identical resolution passed by the U.S. Senate (S. Res. 288) previously. The Senate resolution was sponsored by Senator Patty Murray (WA) and had 5 co-sponsors and was also approved by unanimous consent.

The test of the resolution is:

Whereas mesothelioma is a terminal, asbestos-related cancer that affects the linings of the lungs, abdomen, heart, or testicles;
Whereas workers exposed on a daily basis over a long period of time are most at risk, but even short-term exposures can cause the disease and an exposure to asbestos for as little as one month can result in mesothelioma 20-50 years later;
Whereas asbestos was used in the construction of virtually all office buildings, public schools, and homes built before 1975 and asbestos is still on the United States market in over 3,000 products;
Whereas there is no known safe level of exposure to asbestos;
Whereas millions of workers in the United States have been, and continue to be, exposed to dangerous levels of asbestos;
Whereas the National Institutes of Health reported to Congress in 2006 that mesothelioma is a difficult disease to detect, diagnose, and treat;
Whereas the National Cancer Institute recognizes a clear need for new agents to improve the outlook for patients with mesothelioma and other asbestos-related diseases;
Whereas for decades, the need to develop treatments for mesothelioma was overlooked and today, even the best available treatments usually have only a very limited effect and the expected survival time of those diagnosed with the disease is between 8 and 14 months;
Whereas mesothelioma has claimed the lives of such heroes and public servants as Admiral Elmo Zumwalt, Jr., and Congressman Bruce F. Vento, and a high percentage of today's mesothelioma victims were exposed to asbestos while serving in the United States Navy;
Whereas it is believed that many of the firefighters, police officers, and rescue workers from Ground Zero on September 11, 2001, may be at increased risk of contracting mesothelioma in the future;
Whereas the establishment of a National Mesothelioma Awareness Day would raise public awareness of the disease and of the need to develop treatments and enhance public awareness for it; and
Whereas cities and localities across the country are recognizing September 26 as Mesothelioma Awareness Day: Now, therefore, be it

    Resolved, That the House of Representatives--

      (1) supports the goals and ideals of Mesothelioma Awareness Day; and

      (2) urges the President to issue a proclamation calling on the people of the United States, Federal departments and agencies, States, localities, organizations, and media to annually observe a National Mesothelioma Awareness day with appropriate ceremonies and activities.

Related articles